Alnu Health Perspectives
8 perspectives
Utilizing AI to Enhance the Clinician Experience
AI in healthcare is too often framed around replacing clinical judgment. A more responsible lens: how can it reduce burden and surface what clinicians actually need?
Read article
How Long-Term Continuity of Care Drives GLP-1 Pharmacotherapy Adherence
Adherence to GLP-1 therapy is less about motivation and more about infrastructure. Consistent support structures predict who stays on therapy, and who doesn't.
Read article
The Significance and Necessity of Person-Centered Language When Addressing Obesity and Diabetes
The words clinicians use shape how patients understand and experience care. Language in obesity medicine isn't just semantics; it has measurable clinical implications.
Read article
The Future of Nutrient-Stimulating Hormone (NuSH) Therapies
Beyond GLP-1: what comes next in hormone-based metabolic therapies, and how care delivery must evolve to keep pace with the science.
Read article
Beyond the Shot: Key Insights on the Future of GLP-1 Therapy from Alnu Health's Harvard Business School Panel
Medication is a starting point. What determines long-term outcomes in GLP-1 therapy is the experience built around it: nutrition, coaching, and structured follow-up.
Read article
The Insurance Paradox of GLP-1 Care
Coverage decisions for GLP-1 medications often lag behind clinical evidence. Exploring the gap between what works and what gets reimbursed.
Read article
Reclaiming the Narrative: Why Qualified Clinicians Must Engage in Social Media
Patients are seeking health information online regardless of clinician participation. The question isn't whether to engage; it's how to do it responsibly.
Read articleNo perspectives found
Try a different search term or topic.
See how Alnu fits your care model.
Explore the Alnu Health Platform or talk with our team about fit for your organization.